Effects of topiramate on weight and metabolism in children with epilepsy.
 | Related Articles |
Effects of topiramate on weight and metabolism in children with epilepsy.
Acta Paediatr. 2009 Sep;98(9):1521-5
Authors: Li HF, Zou Y, Xia ZZ, Gao F, Feng JH, Yang CW
AIM: To explore the mechanism of topiramate-induced weight loss in epilepsy children by monitoring metabolism indices. METHODS: Children with epilepsy were treated with topiramate at their first clinical visit. Metabolism indices including body mass index (BMI) and its SD scores, leptin, adiponectin, leptin/adiponectin (L/A), lipid profile-insulin and Homeostasis Model Assessments (HOMA) index were collected before and after treatment. RESULTS: Topiramate treatment significantly reduced L/A (t = 2.156, p = 0.031), and markedly increased the serum level of adiponectin (t = 3.124, p = 0.002). Moreover, there were no relationships between the metabolism indices and dosages of topiramate (p > 0.05). CONCLUSION: Our studies find that topiramate treatment in epilepsy children increases energy metabolism, resulting in weight loss. It has been demonstrated that adiponectin play a significant role in metabolic regulations.
PMID: 19508301 [PubMed - indexed for MEDLINE]
Sponsored Content:
This entry was posted on Wednesday, October 21st, 2009 at 9:18 pm and is filed under Acta Paediatr. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.
